A recent Pfizer-led decentralized trial using a BYOD mobile app revealed that subtle changes in voice biomarkers can indicate early signs of respiratory illness. The study used machine learning to analyze MFCC features and baseline differences, suggesting a promising digital method for early disease detection.
Q&A
- What is a decentralized clinical trial?
- How does baseline subtraction in the tangent space work?
- How does voice biomarker detection differ from conventional tests?